Health Care & Life Sciences » Pharmaceuticals | Shandong Xinhua Pharmaceutical Co. Ltd.

Shandong Xinhua Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
488
436
568
660
909
888
Total Accounts Receivable
574
604
714
557
596
664
Inventories
681
736
652
624
856
1,085
Other Current Assets
54
53
36
64
51
42
Total Current Assets
1,797
1,830
1,971
1,905
2,413
2,679
Net Property, Plant & Equipment
2,493
2,692
2,656
2,672
3,106
3,289
Total Investments and Advances
279
363
333
296
398
318
Intangible Assets
351
391
352
316
388
379
Other Assets
-
-
18
51
-
56
Total Assets
4,943
5,308
5,361
5,269
6,331
6,747
ST Debt & Current Portion LT Debt
761
1,201
1,589
1,683
540
Accounts Payable
308
451
454
483
636
Income Tax Payable
2
9
4
7
3
Other Current Liabilities
256
342
282
360
610
Total Current Liabilities
1,327
2,003
2,328
2,533
1,790
Long-Term Debt
1,138
795
513
184
1,175
Provision for Risks & Charges
-
16
4
4
-
Deferred Taxes
16
14
19
27
5
Other Liabilities
5
-
-
-
-
Total Liabilities
2,478
2,833
2,858
2,722
2,985
Common Equity (Total)
2,254
2,276
2,249
2,218
2,977
Total Shareholders' Equity
2,254
2,276
2,249
2,218
2,977
Total Equity
2,301
2,390
2,368
2,320
3,096
Liabilities & Shareholders' Equity
4,943
5,308
5,361
5,269
6,331
Accumulated Minority Interest
48
114
119
101
119
Non-Equity Reserves
164
85
135
227
249

About Shandong Xinhua Pharmaceutical Co.

View Profile
Address
No. 1 Lutai Avenue
Zibo Shandong 255086
China
Employees -
Website http://www.xhzy.com
Updated 07/08/2019
Shandong Xinhua Pharmaceutical Co., Ltd. engages in the development, production and sales of pharmaceutical and synthetic chemical products. It operates the business through the following segments: Bulk Pharmaceuticals, Preparations, Chemical and Other Products. The firm's products include analgin, caffeine, amidopyrine, ibuprofen, theophylline, aspirin, hydrocortisone and pipemidic acid.